Author Correction: Single-cell transcriptomics stratifies organoid models of metabolic dysfunction-associated steatotic liver disease

EMBO J. 2024 Dec;43(24):6792-6795. doi: 10.1038/s44318-024-00308-w.

Anja Hess^{1

2}, Stefan D Gentile^{1

3}, Amel Ben Saad¹, Raza-Ur Rahman¹, Tim Habboub¹, Daniel S Pratt^{1

4}, Alan C Mullen^{5

6

7

8

9}

¹ Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
² Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
³ Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
⁴ Autoimmune and Cholestatic Liver Center, Massachusetts General Hospital, Boston, MA, USA.
⁵ Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. [email protected].
⁶ Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].
⁷ Harvard Stem Cell Institute, Cambridge, MA, USA. [email protected].
⁸ Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Boston, MA, USA. [email protected].
⁹ University of Massachusetts Chan Medical School, Worcester, MA, USA. [email protected].

Abstract